Doctorglasses Chain Co.,Ltd.

SZSE:300622 Stock Report

Market Cap: CN¥7.5b

Doctorglasses ChainLtd Future Growth

Future criteria checks 1/6

Doctorglasses ChainLtd is forecast to grow earnings and revenue by 18.2% and 11.5% per annum respectively. EPS is expected to grow by 18.3% per annum. Return on equity is forecast to be 19.5% in 3 years.

Key information

18.2%

Earnings growth rate

18.3%

EPS growth rate

Specialty Retail earnings growth19.2%
Revenue growth rate11.5%
Future return on equity19.5%
Analyst coverage

Low

Last updated18 Apr 2025

Recent future growth updates

No updates

Recent updates

These 4 Measures Indicate That Doctorglasses ChainLtd (SZSE:300622) Is Using Debt Reasonably Well

Mar 18
These 4 Measures Indicate That Doctorglasses ChainLtd (SZSE:300622) Is Using Debt Reasonably Well

Returns At Doctorglasses ChainLtd (SZSE:300622) Are On The Way Up

Feb 24
Returns At Doctorglasses ChainLtd (SZSE:300622) Are On The Way Up

What Doctorglasses Chain Co.,Ltd.'s (SZSE:300622) 32% Share Price Gain Is Not Telling You

Dec 20
What Doctorglasses Chain Co.,Ltd.'s (SZSE:300622) 32% Share Price Gain Is Not Telling You

Here's Why Doctorglasses ChainLtd (SZSE:300622) Can Manage Its Debt Responsibly

Nov 24
Here's Why Doctorglasses ChainLtd (SZSE:300622) Can Manage Its Debt Responsibly

There's Reason For Concern Over Doctorglasses Chain Co.,Ltd.'s (SZSE:300622) Massive 25% Price Jump

Nov 05
There's Reason For Concern Over Doctorglasses Chain Co.,Ltd.'s (SZSE:300622) Massive 25% Price Jump

Investors Will Want Doctorglasses ChainLtd's (SZSE:300622) Growth In ROCE To Persist

Oct 02
Investors Will Want Doctorglasses ChainLtd's (SZSE:300622) Growth In ROCE To Persist

Some Confidence Is Lacking In Doctorglasses Chain Co.,Ltd. (SZSE:300622) As Shares Slide 27%

Sep 15
Some Confidence Is Lacking In Doctorglasses Chain Co.,Ltd. (SZSE:300622) As Shares Slide 27%

Estimating The Fair Value Of Doctorglasses Chain Co.,Ltd. (SZSE:300622)

Aug 28
Estimating The Fair Value Of Doctorglasses Chain Co.,Ltd. (SZSE:300622)

Investors Appear Satisfied With Doctorglasses Chain Co.,Ltd.'s (SZSE:300622) Prospects As Shares Rocket 38%

Jul 30
Investors Appear Satisfied With Doctorglasses Chain Co.,Ltd.'s (SZSE:300622) Prospects As Shares Rocket 38%

Solid Earnings Reflect Doctorglasses ChainLtd's (SZSE:300622) Strength As A Business

Apr 09
Solid Earnings Reflect Doctorglasses ChainLtd's (SZSE:300622) Strength As A Business

Doctorglasses Chain Co.,Ltd.'s (SZSE:300622) Shares Bounce 28% But Its Business Still Trails The Market

Mar 07
Doctorglasses Chain Co.,Ltd.'s (SZSE:300622) Shares Bounce 28% But Its Business Still Trails The Market

Earnings and Revenue Growth Forecasts

SZSE:300622 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20271,700184N/A1922
12/31/20261,522162N/A3202
12/31/20251,354137N/A1532
12/31/20241,203104250276N/A
9/30/20241,186114230256N/A
6/30/20241,178114224246N/A
3/31/20241,162116228251N/A
12/31/20231,176128259281N/A
9/30/20231,137125285305N/A
6/30/20231,104122261286N/A
3/31/20231,051106239265N/A
1/1/202396276182208N/A
9/30/202295678159192N/A
6/30/202292370154192N/A
3/31/202290680156197N/A
1/1/202288795171214N/A
9/30/2021873108167205N/A
6/30/2021818108166198N/A
3/31/202175896119146N/A
12/31/20206566976102N/A
9/30/2020613486097N/A
6/30/2020607434183N/A
3/31/2020605453987N/A
1/1/2020655624398N/A
9/30/2019631562778N/A
6/30/2019610581463N/A
3/31/201958960449N/A
12/31/201856659-437N/A
9/30/201853759N/A34N/A
6/30/201850857N/A40N/A
3/31/201848755N/A47N/A
12/31/201747152N/A62N/A
9/30/201745749N/A77N/A
6/30/201744042N/A71N/A
3/31/201743141N/A72N/A
12/31/201641638N/A67N/A
3/31/201638737N/A65N/A
12/31/201537635N/A48N/A
12/31/201436134N/A57N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 300622's forecast earnings growth (18.2% per year) is above the savings rate (2.7%).

Earnings vs Market: 300622's earnings (18.2% per year) are forecast to grow slower than the CN market (23.8% per year).

High Growth Earnings: 300622's earnings are forecast to grow, but not significantly.

Revenue vs Market: 300622's revenue (11.5% per year) is forecast to grow slower than the CN market (12.6% per year).

High Growth Revenue: 300622's revenue (11.5% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 300622's Return on Equity is forecast to be low in 3 years time (19.5%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/09 02:28
End of Day Share Price 2025/05/09 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Doctorglasses Chain Co.,Ltd. is covered by 3 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jia Ren LiuIndustrial Securities Co. Ltd.
Wenzheng LiuMinsheng Securities Co.
Sun-Hai YangTianfeng Securities Brokerage Co., Ltd